Bristol-Myers Squibb Company
NYSE: BMY
$58.50
+$0.09 (+0.2%)
Closing Price on November 14, 2024
BMY Articles
Bristol-Myers, Mattel, DryShips, and FuelCell Energy posted new 52-week lows Thursday.
Published:
Last Updated:
The January 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mostly down.
Published:
Last Updated:
Bristol-Myers, DryShips, Michaels, and Meridian Bioscience sink into Wednesday's 52-week low club.
Published:
Last Updated:
The health care sector has some of its biggest players reporting later this week, with one pharma giant’s report already out of the way.
Published:
Last Updated:
Bristol-Myers, DryShips, Target, and Fitbit posted new 52-week lows on Friday.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Friday include Alphabet, Amazon, Bristol-Myers, CBS, Check Point, CSX, Facebook and PayPal.
Published:
Last Updated:
The short interest data have been released for the December 30 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through...
Published:
Last Updated:
The December 15 short interest data have been compared with the previous figures, and short interest increased in most of these selected pharmaceutical stocks.
Published:
Last Updated:
Portola Pharmaceuticals shares saw a handy gain on Monday after it was reported that the company had received a key loan.
Published:
Last Updated:
Monday’s top analyst upgrades, downgrades and initiations include Anadarko Petroleum, Bristol-Myers Squibb, Comcast, Walt Disney and Merck.
Published:
Last Updated:
The November 30 short interest data have been compared with the previous figures, and short interest decreased in these selected pharmaceutical stocks.
Published:
Last Updated:
The November 15 short interest data have been compared with the previous figures, and short interest was mixed in the selected pharmaceutical stocks.
Published:
Last Updated:
Drug prices have been under pressure due to the campaign rhetoric, and short interest has increased in most of these selected pharmaceutical stocks.
Published:
Last Updated:
Bristol-Myers Squibb Co. (NYSE: BMY) is scheduled to release third-quarter financial results before markets open on Thursday. The consensus estimates from Thomson Reuters are calling for $0.65 in...
Published:
Last Updated:
The October 14 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest was mixed.
Published:
Last Updated: